Magera et al, 1999, J. Labelled Compounds and Radiopharmaceuticals, vol. 42, pp. 683-699.* |
Anderson et al, 1995, Nucl. Med. Biol., vol. 22, No. 2, pp. 165-173.* |
Abrams et al., “Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats,”, J. Nucl. Med., 31:2022-2028, 1990. |
Baidoo and Lever, “Evaluation of a diaminedithiol-based bifunctional chelate for labeling small molecules with 99mTc,” Technetitum and Rhenium in Chemistry and Nuclear Medicine, 1990 |
Blakenberg et al., “Imaging of apoptosis (programmed cell death) with 99mTC annexin V.,” J. Nucl. Med., 40:184-191, 1999. |
Bush et al., “Definitive evidence for hypoxic cells influencing cure in cancer therapy,” Br J Cancer, (Suppl. III) 37:302-306, 1978. |
Campbell et al., “Folate-binding protein is a marker for ovarian cancer,” Cancer Res, 51:5329-5338, 1991. |
Cherif et al., “Rapid synthesis of [18F]Fluoro-1-(2′-Nitro-1′-Imidazolyl)-2-Propanol([18F]Fluoromisonidazole),” Pharm Res., 11:466-469, 1994. |
Coney et al., “Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing,” Cancer Res, 54:2448-2455, 1994. |
Davison et al., “A new class of oxotechnetium(5+)chelate complexes containing a TcON2S2 Core,” Inorg Chem, 20:1629-1632, 1980. |
Dezutter et al., “Preparation and biological evaluation of technetium-99m-L, L-propylenedicysteine” J. of Labelled Cpd. Radiopharm., 42:553-565, 1999. |
Dische, “A review of hypoxic-cell radiosensitization,” Int J Radiat Oncol Biol Phys, 20:147-152, 1991. |
Eisenhut et al., “Synthesis and In Vivo Testing of a bromobutyl substituted 1,2-Dithia-5,9-diazacycloundecane: a versatile precursor for new 99mTc-bis(aminoethanethiol) complexes,” Nucl. Med. Biol., 16:805-811, 1989. |
Franklin et al., “New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarinoma,” Int J Cancer-Supplement, 8:89-95, 1994. |
Goh et al., “Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis,” Endrocrinology, 139:4364-4372, 1998. |
Goldsmith et al., “Somatostatin receptor imaging in lymphoma,” Sem Nucl Med, 25:262-271, 1995. |
Goldsmith, “Receptor imaging: Competitive or complementary to antibody imaging,” Sem Nucl Med., 27:85-93, 1997. |
Hay et al., “Hypoxia-selective antitumor agents. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitizers,” J Med. Chem., 37:381-391, 1994. |
Holm et al., “Folate receptor of human mammary adenocarcinoma,” APMIS, 102:413-419, 1994. |
Hsueh and Dolnick, “Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium,” Biochem Pharmacol, 45:2537-2545, 1993. |
Ilgan et al., “99mTc-ethylenedicysteine-folate: a new tumor imaging agent, synthesis, labeling and evaluation in animals,” Cancer Biotherapy & Radiopharmaceuticals, 13:427-435, 1998. |
Jamar et al., “Clearance of the new tubular agent Tc-99m L,L-ethylenedicysteine: Estimation by a simplified method,” Abstract, J Nucl Med, 34:129P, 1993. |
Jamar et al., “Clinical evaluation of Tc-99m L, L-ethylenedicystein, a new renal tracer, in transplanted patients,” Abstract, J Nucl Med, 35:129P, 1993. |
Kabasakal et al., “Clinical comparison of technetium-99m-ec, technetium-99m-MAG3 and iodine-131-OIH in renal disorders,” J. Nucl. Med., 36(2):224-228, 1995. |
Kabasakal et al., “Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio,” J. Nucl. Med., 36(8):1398-1403, 1995. |
Kabasakal et al., “Prospective validation of single plasma sample 99mTc-ethylenedicysteine clearance in adults,” J. Nucl. Med., 40:429-431, 1999. |
Kabasakal et al., Simplified technetium-99m-EC clearance in adults from a single plasma sample, J. Nuclear Med., 38:1784-1786, 1997. |
Koh et al., “Imaging of hypoxia human tumors with [F18]fluoromisonidazole,” Int J Radiat Oncol Biol Phys, 22:199-212, 1992. |
Kranz et al., “Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis,” Proc Natl Acad Sci, 92:9057-9061, 1995. |
Lamberts et al., “Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostain analog,” J. Steoid Biochem Mol Biol, 37:1079-1082, 1990. |
Leamon and Low, “Cytotoxicity of momordin-folate conjugates in cultured human cells,” J Biol Chem, 267:24966-24971, 1992. |
Leamon and Low, “Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis,” Proc Natl Acad Sci, 88:5572-5576, 1991. |
Leamon et al.,, “Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor cells,” J Biol Chem, 268:24847-24854, 1993. |
Lee and Low, “Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis,” J Biol Chem, 269:3198-3204, 1994. |
Liang et al., “The use of diaminodithiol for labeling small molecules with technetium-99m,” Nucl. Med. Biol., 14:63-67, 1987. |
Lu, “Antimitotic agents,” In: Foye, WO. Ed., “Cancer chemotherapeutic agents,” Washington, DC: American Chemical Society, 345-368, 1995. |
Mathias et al., “Indium-111-DTPA-folate as a radiopharmaceutical for targeting tumor-associated folate binding protein (Abstract),” J Nucl Med, (Supplement) 38:133P, 1997b. |
Mathias et al., “Synthesis of Tc-99m-DTPA-folate and preliminary evaluation as a folate-receptor-targeted radiopharmaceutical (Abstract),” J Nucl Med, (Supplement); 38:87P, 1997a. |
Mathias et al., “Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium-67-deferoxamine-folate,” J Nucl Med, 37:1003-1008, 1996. |
Mochizuki et al., “Synthesis of poly-L-glutamates containing 5-substituted uracil moieties,” Nucleic Acids Symp. Ser., 16:121-124, 1985. |
Moran, “Technetium-99m-EC and other potential new agents in renal nuclear medicine,” Seminars in Nucl. Med., 29:91-101, 1999. |
Mrhac et al., “Abnormal first-pass flow through the azygos vein from valsalva maneuver,” Clinical Nucl. Med., 21:331-332, 1996. |
Orr et al., “Similarity of folate receptor expression in UMSCC 38 cells to squamous cell carcinoma differentiation markers,” J Natl Cancer Inst, 87:299-303, 1995. |
Ozker et al., “Technetium-99m-N,N-ethylenedicysteine-a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease,” J. Nucl. Med., 35:840-845, 1994. |
Piper et al., “A synthetic approach to poly(γ-glutamyl) conjugates of methotrexate,” J. Med. Chem., 26:291-294, 1983. |
Prvulovich et al., “Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure,” J. Nucl. Med., 38:809-814, 1997. |
Raffauf et al., “Colchicine. Derivatives of trimethylcolchicinic acid,” J. Am Chem Soc, 75:5292-5294, 1953. |
Rasey et al., “Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia,” Int. J. Radiat Oncol. Biol Phys, 17:985-991, 1989. |
Rasey et al., “Characteristics of the binding of labeled fluoromisonidazole in cells in vitro,” Radiat Res, 122:301-308, 1990. |
Ross et al., “Differential regulation of folate receptor isoforms in normal and malignant tissue in vivo and in established cell lines,” Cancer, 73:2432-2443, 1994. |
Seabold et al., “Comparison of 99mTc-Methoxyisobutyl Isonitrile and 201 Tl Scintigraphy for Detection of Residual Thyroid Cancer After 131I Ablative Therapy,” J. Nucl. Med., 10(9):1434-1440, 1999. |
Stoffel et al., Evaluation of technetium-99m-L,l-ec in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine 125-OIH, J. Nucl. Med., 35:1951-1958, 1994. |
Tait and Smith, “Site-specfic mutagenesis of annexin V: role of residues from Arg-200 to Lys-207 in phospholipid binding,” Arch Biochem Biophys, 288:141-144, 1991. |
Taylor et al., “Comparison of technetium-99m-LL-EC isomers in rats and humans,” J. Nucl. Med., 38:821-826, 1997. |
Ugur et al., “Technetium-99m-ethylenedicysteine: an alternative agent to detect renovascular hypertension,” J. of Nuclear Med., 38:1662-1664, 1997. |
Ugur et al., “Renovascular hypertension due to takayasu's arteritis demonstrated by Tc-99m ethylenedicysteine captopril scintigraphy,” Clinical Nuclear Medicine, 21:714-716, 1996. |
Ugur et al., “Technetium-99m-ethylenedicysteine in the diagnosis and follow-up of renovascular hypertension,” Investigative Radiology, 31:378-381, 1996. |
Valk et al., “Hypoxia in human gliomas: Demonstration by PET with [18F]fluoromisonidazole,” J Nucl Med, 33:2133-2137, 1992. |
Van Schepdael et al., “Capillary electrophoretic analysis of ethylene dicysteine, a precursor of the radiopharmaceutical 99mTc ethylene dicysteine,” J. Chromatography B, 697:251-254, 1997. |
Verbruggen et al., “Tc-99m-L,L-ethylenedicysteine: A renal imaging agent. I. Labeling and evaluation in animals,” J Nucl Med, 33:551-557, 1992. |
Wang et al., “Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical,” Bioconjugate Chem, 8:673-679, 1997. |
Wang et al., “Synthesis, purification, and tumor cell uptake of67Ga deferoxamine-folate, a potential radiopharmaceutical for tumor imaging,” Bioconjugate Chem, 7:56-62, 1996. |
Weitman et al., “Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis,” Cancer Res, 52:6708-6711, 1992b. |
Weitman et al., “Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues,” Cancer Research, 52:3396-3401, 1992. |
Westerhof et al., “Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: Role of carrier-and receptor-mediated transport systems,” Cancer Res, 51:5507-5513, 1991. |
Yang et al., “Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia,” Radiology, 194:795-800, 1995. |
Yang et al., “Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole,” Pharmaceutical Research, 15:743-750, 1999. |
Zakko et al., “Biliary excretion of Tc-99m ec in renal studies,” Clinical Nuclear Medicine, 23:417-419, 1998. |
Zareneyrizi et al., “Synthesis of [99mTc] ethylenedicysteine-colchicine for evaluation of antiagiogenic effect,” Anti-Cancer Drugs, 10:685-692, 1999. |
Sun et al (1996), J. Med. Chem., vol. 39, No. 2, pp. 458-470.* |
Alper et al., “Assessment of renal functional changes follwing transurethral prostatectomy suing tc-99m ethylenedicystein,” J. Nuclear Med., 37:289P, Abstract No. 1292, 1996. |
Anderson et al., “N,N'-ethylene-di-l-cysteine (ec) complexes of ga(III) and In (III): molecular modeling, thermodynamic stability and in vivo studies,” Nucl. Med. Biol., 22:165-173, 1995. |
Baidoo et al., “Synthesis of a new diaminedithiol bifunctional chelate for the preparation of nuetral technetium complexes,” J. Nuclear Med., 31:806, Abstract No. 414, 1990. |
Bakker et al., “Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity and in vivo application in animals,” J. Nucl. Med., 31:1501-1509, 1990. |
Bar-Server et al., “Comparison of living related donor and recipient renograms in predicting the early postransplantation course,” J. Nuclear Med., 37:292P, Abstract No. 1305, 1996. |
Blondeau et al., “Dimerization of an intermediate during the sodium in liquid ammonia reduction of L-thiazolidine-4-carboxylic acid,” Can J. Chem, 45:49-52, 1967. |
Chen et al., “Biological and pharmacokinetic evaluation of tc-99m ma2g2-b: a potential renal agent,” J. Nuclear Med, 35:263P, Abstract No. 1082, 1994. |
Cleynhens et al., “Synthesis and biological evaluation in mice of a monoamide derivative of tc-99m-1,1-ec,” J. Nuclear Med., 38:186P, Abstract No. 799, 1997. |
Corliji et al., “Contribution of radiolytically induced dissociation of 99mtc--d,1-hmpao in aqueous solutions,” J. Nuclear Med., 31:806, Abstract No. 413, 1990. |
Craig et al., “Renal outcomes for children on year after urinary tract infection,” J. Nuclear Med., 37:46P, Abstract No. 175, 1996. |
Dagli et al., “Analysis of the complete dynamic scan data for camera-based determination of renal function,” J. Nuclear Med., 37:91P, Abstract No. 354, 1996. |
de Klerk et al., “Aspirin versus captopril renography in the diagnosis of renal artery stenosis,” J. Nuclear Med., 37:289P, Abstract No. 1291, 1996. |
Dewanjee et al., “Labeling antisense oligodeoxynucleotide (on) with tc-99m and hybridization with c-myc onecogene mrna in p388 leukemic cells,” J. Nuclear Med., 35:263P, Abstract No. 1081, 1994. |
Eshima et al., “Evaluating the role of protein binding on the renal extraction of tc-99m tubular agents utilizing an isolated perfused rat kidney model,” J. Nuclear Med., 37:47P, Abstract No. 178, 1996. |
Fanciulli et al., “Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cells,” Oncology Res., 6:405-409, 1994. |
Giraud et al., “Application to a cartliage targeting strategy: Synthesis and in vivo biodistribution of 14C-labelled quaternary ammonium-glucosamine conjugates,” Bioconjug. Chem., 11:212-218, 2000. |
Guozheng and Boli, “A new potential renal imagining agent 99mtcn-ec,” J. Labelled compounds and Radiopharmaceuticals, XXXVII:797-798, 1995. |
Hadley et al, “Magnetic resonance imagingin in acute head injury,” Clin. Rad., 39:131-139, 1988. |
Harada et al., “Insulin-induced egr-1 expression in chineses hamster ovary cells in insulin receptor an dinsulin receptor substrate-1 phosphorylation-independent,” J. Biol. Chem., 270:26632-26638, 1995. |
Hermann and Patel, “Adaptive recognition by nucleic acid aptamers,” Science, 287:820-825, 2000. |
Itoh et al., “Graphic (patlak) method in tc-99m-mag3 renal scintigraphy: noninvasive calculation of extraction fraction (ef) and renal plasma flow (RPF),” J. Nuclear Med., 37:291P, Abstract No. 1300, 1996. |
John et al., “Tc-99m labeled ethylenediamines: quest for sigma receptor chelates,” J. Nuclear Med., 38:186P, Abstract No. 798, 1997. |
Jones and Mayer, “Glucose metabolism in the rat small intestine: the effect of glucose analogues on hexokinase activity,” Biochem. J, 132:125-128, 1973. |
Kanvide et al., “Technetium-99m-γ-pyrones: a new class of tc-99m cationic complexes,” J. Nuclear Medicine, 31:908, Abstract, 1990. |
Kao et al., “Role of radioisotope penile plethysmigraphy in the evaluation of penile hemodynamic of impotent patients,” J. Nuclear Med., 37:292P, Abstract No. 1304, 1996. |
Kengen, “Good results of tc-99m-mag3 clearance measurements with a dual headed gamma camera without plasma smapler,” J. Nuclear Med., 37:91P, Abstract No. 353, 1996. |
Kikukawa et al., “Early and delayed Tc-99m ECD brain SPECT in SLE patients with CNS involvement,” Ann Nucl Med. 14:25-32, 2000. |
Kim et al., “Synthesis, biodistribution and imaging of mammary tumors using 99mtc-ec-polyglutamate; a glutamate receptor peptide,” J. Nuclear Medicine, 41:231P Abstract, 2000. |
King et al., “Imaging of bone infection with labelled white blood cells: role of contemporaneous bone marrow imaging,” Dept. Dia. Rad., pp. 148-151, 1990. |
Knight et al., “Radiolabeling of fibrinogen using the lodogen technique,” Throm. Res. Cen. Dept. Biochem., pp. 593-596, 1982. |
Knight et al, “Thrombus imgaing with technetium--99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets,” J. Nucl. Med., 35:282-288, 1991. |
Mang'era and Verbruggen, “Synthesis and evaluation of beta-homocystein derivatives of 99mtc-1,1-ec and 99 mtc-1,1-ecd,” J. of Labelled Compounds and Radiopharmaceuticals, 42:683-699, 1999. |
Martin et al., “Enhanced binding of the hypoxic cell marker [3H]fluoromisondidazole in ischemic myocardium,” J Nucl Med, 30:194-201, 1989. |
Mason et al., “99mtc-desferoxamine: production, stability and solute clearance measurements after aerosolization,” J. Nuclear Med., 31:908, Abstract No. 865, 1990. |
Mather et al., “Tumour cell uptake of technetium dithiocarbamate complexes,” J. Nuclear Med., 38:186P, Abstract No. 797, 1997. |
Mease et al., “Comparison of renal agents for detecting unilateral acute ischemic/reperfusion renal injury in rats,” J. Nuclear Med., 36:231P, Abstract No. 1033, 1995. |
Michiels et al., “Simultaneous estimation of effective renal plasma flow and glomerular filtration rate using tc-99-m-ec.,” J. Nuclear Med., 37:91P, Abstract No. 355, 1996. |
Moller et al., “Biologic activities of naturally occurring human insulin receptor mutations,” J. Biol. Chem., 266:10995-11001, 1991. |
Morton et al., “Comparison of 2-point postural drainage with diuresis renography in the assessment hydronephrosis,” J. Nuclear Med., 37:46P, Abstract No. 174, 1996. |
Nosco et al., “Development of a kit formulation for 99mtcmag3 of very high purity and very high stability,” J. Nuclear Med., 31:908, Abstract No. 863, 1990. |
Offield et al., “PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum,” Development, 122:983-995, 1996. |
Patrick et al., “Folate receptors as potendal therapeutic targets in choroid plexus tumors of SV40 transgenic mice,” J. Neurooncol, 32:111-123, 1997. |
Pirmettis et al., “Synthesis and characterization of the tcd(ec) complex, a renal imaging agent,” J. Nuclear Med., 35:263P, Abstract No. 1079, 1994. |
Popovici et al., “The influence of some antibiotics on hexokinase and pyruvate-kinase activity in the rat liver and kidney,” Arch. int. Pharmacodyn, 193:80-86, 1971. |
Ratner and Clarke, “The action of formaldehyde upon cysteine,” J. Am Chem. Soc., 59:200-206, 1937. |
Rogers et al., “Neomycin effects on glucose transport by rat small intestine,” Digestion, 1:159-164, 1968. |
Sasaki et al., “Assessment of antioxidative ability in brain: imaging of glutathione localization with technetium-99m meso-hexamethyl propyleneamine,” J. Nuclear Med., 35:263P, Abstract No. 1083, 1994. |
Sato et al., “Simple estimation of fractional renal uptake of tc-99m mag3 using graphical analysis without syringe counting and renal depth correction,” J. Nuclear Med., 37:292P, Abstract No. 1303, 1996. |
Shankar et al., “Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependend diabetes mellitus,” Metabolism, 47:573-577, 1998. |
Shattuck et al., “Validation of the two sample technique for measuring gfr in renal transplant patients,” J. Nuclear Med., 36:231P, Abstract No. 1036, 1995. |
Shuke et al., “Modified renal counting method for estimation of tc-99m mag3 renal clearance,” J. Nuclear Med., 37:291P, Abstract No. 1031, 1996. |
Skrzypczak-Jankun et al., “Structure of the hirugen and hirulog 1 complexes of α-thrombin,” J. Mol. Biol., 221:1379-1393, 1991. |
Subramanian et al., “Transschelation reactions in labeling ecd with tc-99m,” J. Nuclear Med., 31:908, Abstract No. 867, 1990. |
Surma et al., “Usefulness of Tc-99m-N,N′-ethylene-1-dicystein complex for dynamic kidney investigations,” Nucl Med Comm, 15:628-635, 1994. |
Suzuki et al., “A modified graphic method for estimation of glomerular filtration index using dynamic renal images with tc-99m dtpa,” J. Nuclear Med., 36:231P, Abstract No. 1035, 1995. |
Taylor et al., “Comparison of tc-99m0(n,n1-ethylenedicystein isomers in rats and in normal volunteers,” J. Nuclear Med., 37:46P, Abstract No. 177, 1996. |
Taylor et al., “Comparison of technetium-99m-LL-EC isomers in rats and humans,” J. Nucl. Med., 38:821-826, 1997. |
Tsukamoto et al., “The quantitation of absolute tc-99m-dmsa renal uptake in children from planar posterior-view method,” J. Nuclear Med., 37:291P, Abstract No. 1299, 1996. |
Tubis et al., “The preparation of 99mtechnetium-labelled cystine, methionine and synthetic polypetide and their distribution in mice,” Int;. Journ. Appl. Rad. Isotop., 19:835-840, 1968. |
Tuli et al., “Comparison of a simplified quantitation of tc-99m mag-3 renogram to core needle biopsy in the diagosis of renal transplant rejection,” J. Nuclear Med., 37:289P, Abstract No. 1290, 1996. |
Ugur et al., “Technetium-99m-ethylenedicysteine in the diagnosis and follow-up of renovascular hypertension,” Investigative Radiology, 31:378-381, 1996. |
Ugur et al., “The diagnosis of renovascular hypertension with tc-99m ethylenedicysteine captopril scintigraphy,” Investigative Radiology, 31:497-501, 1996. |
Van Nerom et al., “Comparative evaluation of Tc-99m L,L-ethylenedicystein and Tc-99m MAG3 in volunteers,” Eur J Nucl Med, 16:417, 1990. |
Van Nerom et al., “Comparison of renal excretion ocharacteristics of isomers, 1,1 and d,d of tc-99m ethylenedicystein,” J. Nuclear Med., 31:806, Abstract No. 412, 1990. |
Van Nerom et al., “Optimalization of the labelling of ethylenedicystein (ec) with technetium-99m,” J. Labelled Compounds and Radiopharmaceuticals, XXX:37-39, 1991. |
Van Nerom et al., “First experience in healthy volunteers with Tc-99m-L,L-ethylenedicstein, a new renal imaging agent,” Eur J Nucl Med, 20:738-746, 1993. |
Verbruggen et al., “Evaluation of Tc-99m-L,L-ethylenedicysteine as a potential alternative to Tc-99m MAG3,” Eur J Nucl Med, 16:429, 1990. |
Verbruggen et al., “Is syn or anti orientation of the oxotechnetium and carboxyl group in tc-99m renal function agents affecting the renal excretion rate?” J. Labelled Compounds and Radiopharmaceuticals, XXX:86-88, 1991. |
Verbruggen et al., “Tc-99m 1,1-ethylenedicystein, a potential alternative to tc-99m mag3,” J. Nuclear Med., 31:908, Abstract No. 864, 1990. |
Villevalois-Cam et al., “Insulin-induced redistribution of the insulin-like growth factor II/mannose 6-phosphate receptor in tact rat liver,” J. Cell. Biochem., 77:310-322, 2000. |
Walsh et al., “Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infaction,” J. Nucl. Med., 30:1798-1808, 1989. |
Washburn et al., “Reliable kit preparation of tc99m pentavalent dimercaptosuccinic acid [tc-99m (v) dmsa], ” J. Nuclear Med., 35:263P, Abstract No. 1080, 1994. |
Weir et al, “Prognostic value of single-photon emission tomography in acute ischaemic strike,” Eur. Journ. Nuc. Med., 24:21-26, 1989. |
Weitman et al., “The folate receptor in central nervous system malignancies of childhood,” J Neuro-Oncology, 21:107-112, 1994. |
Yang et al., “99mtc-ec-deoxyglucose: synthesis, cellular uptake, biodistribution an dscintigraphic imaging,” J. Labelled Cpd. Radiopharm., 44:S513-S514, Abstraction 2001. |
Yang et al., “Imaging tumor folate receptors using 99mtc-ethylenedicystein-folate,” Proceedings of the American Association for Cancer Research, 40:259, Abstract #1720, 1999. |
Yang et al., “Imaging tumor folate receptors using radiolabels folate and methotrexate,” J. Labelled Cpd. Radiopharm., 42:S696-S697, 1999. |
Yang et al., “Molecular imaging using 99m-tc-ec-nitroimidazole, and 99mtc-ec-annexin v in tumor-bearing rodents,” Proceedings of the American Association for Cancer Research Annual Meeting, 41:766, Abstract, 2000. |
Yoshini et al., “Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats,” Metabolis. 48:1418-23, 1999. |